ADHD treatment trialled in bid to help ice addicts kick deadly habit

Lisdexamfetamine was recently listed on Australia's Pharmaceutical Benefits Scheme for the treatment of attention deficit hyperactivity disorder (ADHD) in children between the age of six and 18 years old. But researchers at Sydney's St Vincent's Hospital ...



from Meta Search Alerts http://ift.tt/1tpkiEs

via IFTTT